Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Mankind Pharma plans manufacturing plant in US, to invest Rs300 crore
BackBack

Mankind Pharma plans manufacturing plant in US, to invest Rs300 crore

Investment is being strategically done with an eye to place the company among top three Indian pharma firms in the US, says Mankind

Mankind is expecting to generate a revenue of `1,000 crore from the international market by 2030.Premium
Mankind is expecting to generate a revenue of `1,000 crore from the international market by 2030.

New Delhi: Mankind Pharma plans to invest around 300 crore to set up a manufacturing plant in New Jersey, US as part of its strategy to become a leading player in the world’s largest drug market.

The investment in the US is being strategically done with an eye to place the company among top three Indian pharma firms in the US, Mankind Pharma on Thursday said in a statement.

“We wish to become a multinational pharma company by tapping the foreign markets. At the same time, we aim to place our self amongst the top three pharmaceutical companies of India. Therefore, US market will come up with new innovative products which will further distinguish us from others," Mankind Pharma chairman and founder R.C. Juneja said.

Mankind is expecting to generate a revenue of 1,000 crore from the international market by 2030. The company, which increasingly focuses on affordable healthcare in India is set to promote same in the US markets, though not compromising on quality, it said.

Mankind has presence in various markets such as Sri Lanka, Myanmar, Cambodia, Kenya, Uganda, Zambia and Tanzania.

“With this new presence in the US, Mankind will bring a huge impact on the research and production of reasonable generic drugs," the company said.

Besides, the company is also planning to export its products to developing markets of Asia and Africa. Moving ahead, the company is planning to enhance its presence in Russia over the next five years. Besides, the company is also focusing on chronic segments, nutraceuticals, cosmetology and newer markets to attract global business.

Mankind Pharma has a strong portfolio of products ranging from pharma to over-the-counter and FMCG brands with an employee base of more than 12,000.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 21 Jan 2016, 10:54 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App